Tocrisolve 100
Tocrisolve 100 is a water-soluble formulation of the lipophilic compound Tocrisolve. It is designed to improve the solubility and bioavailability of lipophilic molecules for in vitro and in vivo applications.
Lab products found in correlation
9 protocols using tocrisolve 100
Cannabinoid Compound Pharmacology Protocol
Apoptosis Pathway Biomarkers Analysis
Cannabinoid Receptor Agonists and Inhibitors
Synthesis and Administration of OEA and CC7
For in vitro molecular biology studies, the drugs were dissolved in dimethyl sulfoxide (DMSO). For in vivo studies in rodents, the drugs were dissolved in 20% Tocrisolve™-100 (Tocris Bioscience, Bristol, UK) and 80% physiological saline. OEA and CC7 were administered intraperitoneally (i.p.) at doses of 5 mg/kg in a volume of 1 mL/kg body weight in rats and 10 mL/kg body weight in mice. A solution of 0.6% acetic acid was prepared in physiological saline.
Inflammatory Mediator Protocols
Neuronal Pharmacological Treatments and Protocols
Cannabidiol Delivery and Receptor Antagonists
Topical CB2R Agonists and Inverse Agonist
Investigating NP-1's Anorectic Properties
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!